WO2004069394A3 - Synthetic method for direct arylation of heterocyclic arenes - Google Patents

Synthetic method for direct arylation of heterocyclic arenes Download PDF

Info

Publication number
WO2004069394A3
WO2004069394A3 PCT/US2004/003215 US2004003215W WO2004069394A3 WO 2004069394 A3 WO2004069394 A3 WO 2004069394A3 US 2004003215 W US2004003215 W US 2004003215W WO 2004069394 A3 WO2004069394 A3 WO 2004069394A3
Authority
WO
WIPO (PCT)
Prior art keywords
mixture
synthetic method
direct arylation
compound
direct
Prior art date
Application number
PCT/US2004/003215
Other languages
French (fr)
Other versions
WO2004069394A2 (en
Inventor
Dalibor Sames
Bengu Sezen
Benjamin S Lane
Original Assignee
Univ Columbia
Dalibor Sames
Bengu Sezen
Benjamin S Lane
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Columbia, Dalibor Sames, Bengu Sezen, Benjamin S Lane filed Critical Univ Columbia
Publication of WO2004069394A2 publication Critical patent/WO2004069394A2/en
Publication of WO2004069394A3 publication Critical patent/WO2004069394A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/323—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to the ring nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/12—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/18—Benzimidazoles; Hydrogenated benzimidazoles with aryl radicals directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/56—Benzoxazoles; Hydrogenated benzoxazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D263/57—Aryl or substituted aryl radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pyridine Compounds (AREA)
  • Catalysts (AREA)

Abstract

Methods for the direct, selective arylation of carbon-hydrogen sites on various heteroaromatic compounds are disclosed. A method of the present invention includes contacting the heteroaromatic compound with a basic compound to form a first mixture, adding a second mixture comprising a catalyst to the first mixture to form a third mixture, and adding an Ar-X compound to the third mixture, wherein Ar comprises an aryl species and X comprises a leaving group.
PCT/US2004/003215 2003-02-03 2004-02-03 Synthetic method for direct arylation of heterocyclic arenes WO2004069394A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US44454203P 2003-02-03 2003-02-03
US60/444,542 2003-02-03

Publications (2)

Publication Number Publication Date
WO2004069394A2 WO2004069394A2 (en) 2004-08-19
WO2004069394A3 true WO2004069394A3 (en) 2005-08-25

Family

ID=32850883

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2004/003215 WO2004069394A2 (en) 2003-02-03 2004-02-03 Synthetic method for direct arylation of heterocyclic arenes

Country Status (1)

Country Link
WO (1) WO2004069394A2 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101472248B1 (en) 2006-02-10 2014-12-16 서미트 코포레이션 피엘씨 Treatment of duchenne muscular dystrophy
SI2170396T1 (en) 2007-08-03 2017-04-26 Summit (Oxford) Limited Drug combinations for the treatment of duchenne muscular dystrophy
AR072297A1 (en) 2008-06-27 2010-08-18 Novartis Ag DERIVATIVES OF INDOL-2-IL-PIRIDIN-3-ILO, PHARMACEUTICAL COMPOSITION THAT INCLUDES THEM AND ITS USE IN MEDICINES FOR THE TREATMENT OF DISEASES MEDIATED BY THE SYNTHESIS ALDOSTERONE.
PE20110843A1 (en) 2008-09-22 2011-12-08 Cayman Chem Co DERIVATIVES OF 5- (1H-IMIDAZOL-5-IL) -2-PHENYLPYRIMIDINE, AS INHIBITORS OF PROSTAGLANDIN D HEMATOPOYETIC SYNTHASE
JP5361316B2 (en) * 2008-10-02 2013-12-04 株式会社タムラ製作所 Surface treatment agent, printed circuit board, and manufacturing method thereof
PL2610248T3 (en) * 2010-08-27 2016-12-30 Method for producing phenyl-substituted heterocyclic derivative by means of coupling method using a palladium compound
JP6046950B2 (en) * 2011-09-02 2016-12-21 高砂香料工業株式会社 Process for producing N- (hetero) arylazoles
US9624181B2 (en) 2012-08-31 2017-04-18 Api Corporation Method for producing biaryl compound
DE102013012685A1 (en) * 2013-07-31 2015-02-05 Johann-Wolfgang-Goethe Universität Frankfurt am Main Arylated pyrazole derivatives and their use as fluorescent dyes
CN105131042B (en) * 2015-07-22 2017-08-25 河南工业大学 Chelating type N-heterocyclic carbine palladium compound containing heteroaryl and preparation method thereof
CN113185462B (en) * 2021-04-26 2022-12-16 上海应用技术大学 Method for catalyzing direct arylation of imidazole compounds by using palladium complex

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
DATABASE CAPLUS [online] 1991, OHTA ET AL: "Palladium-catalyzed arylation of furan, thiopene, benzo[b] furan benzo[b] thiopene", accession no. STN Database accession no. (1991:143031) *

Also Published As

Publication number Publication date
WO2004069394A2 (en) 2004-08-19

Similar Documents

Publication Publication Date Title
WO2004069394A3 (en) Synthetic method for direct arylation of heterocyclic arenes
NO20023080D0 (en) Catalyst, process for making the same, and reactions using the catalyst
WO1991016322A3 (en) Heterocyclic chiral ligands and method for catalytic asymmetric dihydroxylation of olefins
WO2007001803A3 (en) Cure catalyst, composition, electronic device and associated method
ATE507476T1 (en) IMPROVED STRUCTURED-FUNCTIONAL BINDING MATRICES FOR BIOMOLECULES
ID26185A (en) PROCESS FOR IMPLEMENTING CATALYTIC MULTIFASE REACTIONS, ESPECIALLY HYDROFORMILATION
EP1031603A3 (en) Synergistic catalyst system and method for carrying out hydrosilylation reactions
DK1145763T3 (en) Hydrogenation catalyst for hydrocarbon oil, carrier thereof and process for hydrogenation of hydrocarbon oil
WO2004035633A3 (en) Soil stabilizer carrier
WO2000071518A3 (en) Heterocyclic analgesic compounds and their use
NL1009731C8 (en) METHOD AND SYSTEM FOR CORRECTING A CARRIER FREQUENCY SHIFT AND A SPREADING CODE TEMPORIZATION SHIFT IN A COMMUNICATION SYSTEM WITH A SPECTRUM SPREAD BY DIRECTION SEQUENCE.
NO20003257D0 (en) Frequency hopping method, as well as base station
WO2001068604A3 (en) 3-substituted piperidines comprising urea functionality, and methods of use thereof
ATE225358T1 (en) PRODUCTION OF TRANSITION METAL IMINO COMPLEXES
ATE402212T1 (en) METHOD FOR PRODUCING POLYISOCYANATES
WO2000064841A3 (en) Phosphine ligands, metal complexes and compositions thereof for cross-coupling reactions
WO2002069895A3 (en) Heterocyclic analgesic compounds and methods of use thereof
DK1199927T3 (en) Process for making ammonium glyphosate powder
DE602004010711D1 (en) METHOD FOR THE CATALYTIC MANUFACTURE OF HYDROCODON AND HYDROMORPHONE
NO20002220D0 (en) Method of transmission, as well as radio system
DE69938067D1 (en) Process for the removal of organic compounds by means of combustion catalysts
WO2003039456A3 (en) Process for the preparation of aniline-derived thyroid receptor ligands
DE69934948D1 (en) PROCESS FOR THE COOXIDATION OF ORGANIC COMPOUNDS
EA200200205A1 (en) Method for producing adrenaline
DK1418178T3 (en) Flame retardant for polymeric materials

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase